$1.56
6.85% today
Nasdaq, Apr 02, 09:13 pm CET
ISIN
US2312692005
Symbol
CRIS
Sector
Industry

Curis, Inc. Stock price

$1.46
-1.47 50.17% 1M
-3.79 72.19% 6M
-1.60 52.29% YTD
-11.22 88.49% 1Y
-47.14 97.00% 3Y
-11.94 89.10% 5Y
-233.54 99.38% 10Y
Nasdaq, Closing price Tue, Apr 01 2025
-0.64 30.48%
ISIN
US2312692005
Symbol
CRIS
Sector
Industry

Key metrics

Market capitalization $12.36m
Enterprise Value $29.49m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 2.70
P/S ratio (TTM) P/S ratio 1.13
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth 8.83%
Revenue (TTM) Revenue $10.91m
EBIT (operating result TTM) EBIT $-44.54m
Free Cash Flow (TTM) Free Cash Flow $-39.56m
Cash position $20.00m
EPS (TTM) EPS $-7.03
P/E forward negative
P/S forward 1.16
EV/Sales forward 2.76
Short interest 1.71%
Show more

Is Curis, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.

Curis, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Curis, Inc. forecast:

2x Buy
67%
1x Hold
33%

Analyst Opinions

3 Analysts have issued a Curis, Inc. forecast:

Buy
67%
Hold
33%

Financial data from Curis, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
11 11
9% 9%
100%
- Direct Costs 0.66 0.66
42% 42%
6%
10 10
15% 15%
94%
- Selling and Administrative Expenses 16 16
7% 7%
144%
- Research and Development Expense 39 39
2% 2%
353%
-44 -44
7% 7%
-403%
- Depreciation and Amortization 0.56 0.56
39% 39%
5%
EBIT (Operating Income) EBIT -45 -45
8% 8%
-408%
Net Profit -43 -43
8% 8%
-398%

In millions USD.

Don't miss a Thing! We will send you all news about Curis, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Curis, Inc. Stock News

Neutral
Seeking Alpha
2 days ago
Curis, Inc. (NASDAQ:CRIS ) Q4 2024 Earnings Conference Call March 31, 2025 8:30 AM ET Company Participants Diantha Duvall - CFO Jim Dentzer - President and CEO Jonathan Zung - Chief Development Officer Conference Call Participants Sean McCutcheon - Raymond James Li Watsek - Cantor Fitzgerald Ed White - H.C. Wainwright Operator Good morning, and welcome to Curis's Fourth Quarter 2024 Business Up...
Neutral
PRNewsWire
2 days ago
FDA and EMA discussions completed to support a potential accelerated approval path in both US and EU Orphan Drug Designation for PCNSL granted in both US and EU Management to host conference call today at 8:30 a.m. ET LEXINGTON, Mass.
Neutral
PRNewsWire
5 days ago
LEXINGTON, Mass. , March 28, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Company will report its fourth quarter 2024 financial and operating results on Monday, March 31, 2025, at 8:00 a.m.
More Curis, Inc. News

Company Profile

Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170, and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.

Head office United States
CEO James Dentzer
Employees 34
Founded 2000
Website www.curis.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today